Intranasal Insulin Protects Against Type 1 Diabetes

Insulin nasal spray may prevent the development of type 1 diabetes in high-risk patients, according to a new study. Research published this month investigated the safety and immune effects of intranasal insulin in 38 individuals at risk for type 1 diabetes.

Six participants in each arm of the crossover study (intranasal insulin-first and placebo-first groups) developed diabetes a median of 1.1 years from entry.

Eleven of these participants had baseline first-phase insulin responses to intravenous glucose (a measure of beta-cell function) no higher than the first percentile.

Circulating insulin antibodies increased significantly during intranasal insulin treatment, the report indicates.

Intranasal insulin was also associated with significant decreases in T-cell proliferation to insulin.

This is, to our knowledge, the first demonstration in humans of an effect of mucosally administered autoantigen on potential surrogate disease markers,’ say the authors.

‘The ultimate demonstration of this in humans would be the ability of intranasal insulin to prevent or delay diabetes onset,’ they add.

Note: Injectable insulin in past studies have shown no effect in preventing Type 1 diabetes.

Diabetes Care 2004;27:2348-2355

================================

Start your own walking program. New StepTracker Available at special prices. See the results of the Step Program Study. Step Program

Purchase your own pedometers and receive the Steps To Health Program at no charge. Click Here

================================

DID YOU KNOW:

One hour of brisk walking a day cuts your Type II diabetes risk by 50% according to the Nurse’s Health Study. Many physicians recommend walking and exercise to help diabetics with weight and maintaining their blood sugar levels